Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 20/20 | 0.72 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.72 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.66 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4947356 | 0.99 | SLC6A2 (0.70) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4059296 | 0.96 | SLC6A2 (0.71) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4054991 | 0.90 | SLC6A2 (0.66) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4065781 | 0.90 | SLC6A2 (0.73) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4940407 | 0.89 | SLC6A2 (0.65) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| Hydrochloric Acid SCHEMBL4947363 | 0.89 | SLC6A2 (0.72) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4059516 | 0.86 | SLC6A2 (0.67) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4054897 | 0.86 | SLC6A2 (0.62) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4061664 | 0.85 | SLC6A2 (0.67) | SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL4053309 | 0.85 | SLC6A2 (0.73) | SLC6A2SLC6A4SLC6A3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2061776-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | Wyeth a Corporation of the State of Delaware (US) | 2009-05-27 | — | — | EP | claimed |
| US-20080161366-A1 | AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-07-03 | — | — | US | claimed |
| WO-2008073459-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-06-19 | — | — | WO | claimed |
| US-11610742-B2 | Enhanced cycle lifetime with gel electrolyte for MNO2 nanowire capacitors | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-21 | — | — | US | disclosed |
| US-20200152396-A1 | ENHANCED CYCLE LIFETIME WITH GEL ELECTROLYTE FOR MNO2 NANOWIRE CAPACITORS | UNIV CALIFORNIA (US) | 2020-05-14 | — | — | US | disclosed |
| US-10347434-B2 | Enhanced cycle lifetime with gel electrolyte for MNO2 nanowire capacitors | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-07-09 | — | — | US | disclosed |
| EP-1937757-B1 | METHOD FOR THE FABRICATION OF HIGH SURFACE AREA RATIO AND HIGH ASPECT RATIO SURFACES ON SUBSTRATES | NATIONAL CENTER FOR SCIENT RESEARCH DEMOKRITOS (GR) | 2018-10-17 | — | — | EP | disclosed |
| US-20170338056-A1 | ENHANCED CYCLE LIFETIME WITH GEL ELECTROLYTE FOR MNO2 NANOWIRE CAPACITORS | U.S. DEPARTMENT OF ENERGY | 2017-11-23 | — | — | US | disclosed |
| EP-2061776-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | Wyeth a Corporation of the State of Delaware (US) | 2009-05-27 | — | — | EP | disclosed |
| US-20080296260-A1 | Method For the Fabrication of High Surface Area Ratio and High Aspect Ratio Surfaces on Substrates | TSEREPI ANGELIKI | 2008-12-04 | — | — | US | disclosed |
| US-20080161366-A1 | AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-07-03 | — | — | US | disclosed |
| US-20080161366-A1 | AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-07-03 | — | — | US | disclosed |
| US-20080161366-A1 | AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-07-03 | — | — | US | disclosed |
| EP-1937757-A1 | METHOD FOR THE FABRICATION OF HIGH SURFACE AREA RATIO AND HIGH ASPECT RATIO SURFACES ON SUBSTRATES | National Center for Scientific Research Demokritos (GR) | 2008-07-02 | — | — | EP | disclosed |
| WO-2008073459-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008073459-A1 | ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | WYETH (US) | 2008-06-19 | — | — | WO | disclosed |
| WO-2007031799-A1 | METHOD FOR THE FABRICATION OF HIGH SURFACE AREA RATIO AND HIGH ASPECT RATIO SURFACES ON SUBSTRATES | NATIONAL CENTER FOR SCIENTIFIC RESEARCH 'DEMOKRITOS' (GR) | 2007-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161366-A1 | AMINOALKYL SUBSTITUTED ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE | SLC6A4, SLC6A2, SLC6A3 | SLC6A2 2/4885SLC6A4 1/4885SLC6A3 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.